; (B) the type of information collected and stored in the surveillance system; (C) the use and availability of such information, including guidelines for such use; and (D) the use and coordination of databases that collect or maintain information on rare diseases or conditions. (j) Definitions In this section: (1) National voluntary health association The term national voluntary health association means a national nonprofit organization with chapters, other affiliated organizations, or networks in States throughout the United States with experience serving the population of individuals with a rare disease or condition and have demonstrated experience in rare disease or condition research, care, and patient services. (2) Rare The term rare , with respect to a disease or condition, means affecting fewer than 200,000 individuals in the United States. (k) Authorization of Appropriations To carry out this section, there are authorized to be appropriated $5,000,000 for each of fiscal years 2018 through 2023. . (c) AHRQ health care provider awareness activities (1) In general The Director of the Agency for Healthcare Research and Quality shall expand and intensify the activities of the Agency to increase the awareness and knowledge of health care providers about rare diseases and conditions. (2) Definition In this subsection, the term rare diseases and conditions refers to any disease or condition affecting fewer than 200,000 individuals in the United States. (d) National Academies report (1) In general The Secretary of Health and Human Services shall seek to enter into an arrangement with the National Academies (or another appropriate entity if the National Academies decline) to update and republish, by not later than 3 years after the date of enactment of this Act, the 2010 report of the National Academies entitled Rare Diseases and Orphan Products: Accelerating Research and Development . (2) Authorization of appropriations To carry out this subsection, there is authorized to be appropriated $1,000,000.